Uncontrolled Asthma Clinical Trial
Official title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist.
A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist
This is a randomized, double-blind, parallel group, placebo-controlled study designed to
evaluate efficacy and safety of tralokinumab administered subcutaneously in subjects with
uncontrolled asthma on inhaled corticosteroid plus long-acting β2-agonist and having a
history of asthma exacerbations.
Approximately 1140 subjects will be randomized globally. Subjects will receive tralokinumab,
or placebo, administered via subcutaneous injection at the study site, over a 52-week
treatment period.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02194699 -
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
|
Phase 3 | |
| Recruiting |
NCT06029595 -
Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy
|
Phase 2 | |
| Active, not recruiting |
NCT03978936 -
Medication Adherence With Telehealthcare Medication Therapy Management
|
N/A | |
| Completed |
NCT02768623 -
Evaluation of a Community Pharmacist Managed Asthma Consultation Service
|
N/A | |
| Completed |
NCT02906761 -
Aspirin for Uncontrolled Asthma
|
Phase 3 | |
| Completed |
NCT04865575 -
Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
|